Tezepelumab Can Help Reduce Oral Corticosteroid Use in Severe Uncontrolled Asthma

Nearly 90 percent of adults had maintenance OCS dose of 5 mg/day or less after 52 weeks of treatment
trouble breathing or panic attack
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com